Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Bottoms UP!
hahaha... are you going to meet Tke at the bar again tonight? Misery loves company. You can have a drink for 'woulda', 'coulda', and 'shoulda'.
It's hard to fathom how much wealth AMRN FOMO has destroyed. Yup... mind blowing to think that could have been avoided IF a simple trendline was honored.
BTW, knownothing, what is your basis in this stock? Be honest...
You're going to break your rules!? Not me (I never hold over ER unless Price is trading above the 50MA).
I sold on this morning's price squeeze to the top of the Bollinger Bands (as expected).
Looking to reload trade on a pullback before the AHA conference.
Last chance to grab shares this low. Yesterday was a classic exhaustive capitulation that will put in a higher low (1.06... 9/23 low was 1.04). I think this is a technical bottom that will attract buyers :)
Bollinger Band price squeeze will force price back up to 1.27 soon. All we need is the index to goose it today.
Fingers crossed....
Very low volume today. Markets are coiling tightly in front of tomorrows CPI report
....mic drop!
And there it is... more proof of adverse effects:
WANDEROFFACLIFF - Thanks for adding more gun powder to this RALLY!
Can you short some more please?!
Oven is too hot dude! Too much upside momentum... have fun when your shorts catch fire and burn. AMRN will rally when the market digests yesterday's gains.
Risky business shorting biotech companies - especially those near 52-wk lows. When one pops up, the whole complex goes up with it in a flash and leaves you holding the bag on an island reversal.
Nice breakout rally in the XBI/IBB (thank you Biogen). AMRN is tracking.
Today's news is going to force WS to investigate other ongoing ALZ. trials, including BRAVE. Looking forward to MITIGATE blowout results. Then the dots will begin to connect.
nice broad based market reversal underway. index Call option signals flashed this morning.
The changing tide will lift AMRN too (to the chagrin of shorty.... hehehe)
RM - recession not depression.
Strategically selected verbiage?
kiwi, we've debated this before:
In post # 386557 I cited articles that lay out the fragilities in the capital markets and liquidity channels.
Iwanderer…… Blah, blah … So you’re short 150k going into the weekend? Prove it.
“Perfect storm” was in reference to upcoming trial data chain reaction.
Had nothing to do with my “trade”.
BTW, if you truly trade… you must be a FLIP-FLOP artist to be successful scalping the ebbs and flows of algos.
Nope. Not short AMRN. I'm short the indexes via puts, but I have never shorted AMRN. Foolish to short a stock this low with such huge slippage due to the spread between the bid and ask (as a result of the low liquidity).
I think the market would love a 1% aggressive move. It would signal a Fed pivot.
From a TA standpoint, the market is poised to trace a very bullish head and shoulders bottom that is missing the right shoulder (bullish).
Why is this pattern so important? Because it is the same pattern that nailed a bottom in 2009
and the same pattern that ended every subsequent correction since then.
Today's announcement could force a squeeze that takes a giant leap towards putting a nail in an interim bottom.
Nice illustration, thanks. So is this the long awaited defined MOA in terms of V action as a statin enhancer, etc., etc.?
same for you, post your screen shots (include your long losing trades too)
Pinocchio's everywhere on the net.
He's just a med student masquerading as a real doctor.
Yes, I agree.
To some degree however, the US generic Rxs are only a percentage of the whole market, not the totality. If great results force more docs to embrace the drug, more US sales will ensue - not to mention more foreign interest and leverage with reimbursement negotiations.
Those are strong bullet points in favor of BP interest as you mentioned.
At the very least, strong results/resultant sales boost could take the company out of the danger zone of another secondary or worse,… bankruptcy.
Welcome to the perfect storm.
RESPECT - more than confirms R-IT because of the impact of Covid-19 and Covid-19 vaccine side effects. This points to the magnified efficacy of IPE.
Then comes MITIGATE to prove that in this new normal, if your AA:EPA ratio is inadequate, you will forever be at risk of Covid related CVD complications . Wow...
If that isn't enough to move the needle, BRAVE will.
Reuter's : Alzheimer's-like changes found in COVID patients' brains; flu shot, mRNA booster safe together
MITIGATE will be our pleotropic marching band by tying everything together into the AA:EPA ratio - - human's defense against degenerative diseases - amplified and accelerated by Covid-19.
JL's vision might materialize after all...
Perhaps we'll see R-IT gap 2.0?
It has tracked the biotech index fairly closely this week.
That it didn’t cave in to test the recent low is positive.
The SPY broke support of its up trendline this week. If it fails to follow through, we could see buyers step in next week.
The stock price seems to be in a “doji” mode; buyers and sellers are uncertain rightly so until we get news. Without news, the stock will mirror the bio index.
No, I'm not being sarcastic... AMRN performed well today (relatively speaking).
AMRN has an ATR(average true range) of 4.0 vs 1.0 for the biotech index ETF, meaning AMRN should have been down -18% to have identical performance with IBB. Instead, the graph shows a tame retrace of 38% of the recent rally, on light volume... on a day where the markets experienced a mini crash in response to the unexpected CPI#.
This means there are very few sellers and increases the probability we see a resumption of the recent rally.
On another topic, there has been a lot of discussion lately about shorting.
IMO, shorting is a dangerous game especially in an illiquid market like AMRN stock, and in a market that has a big spread between the bid and ask.
on another topic, we've been informed repeatedly of a certain poster who shorts (150k) near the high and covers near the low. It's impossible to be filled without triggering algos that make you chase an entry far away from the intended limit when trading a low priced low volume stock like AMRN,
I've found index puts to be a much safer and more profitable way to short markets - even when entries are post gap open like this morning. The SPY400puts moved +513% today. A pullback entry still enabled a +63% gain
When compared to an AMRN short, it would only require an investment of $13,000 (not $150,000) to have an equivalent gain (+8,250 based on +63% gain vs +5.0%)
Your “instinct” interprets absorption as weakness; cardinal sin for most bears…
BTW, your math isn’t adding up. Post a screen shot of your trades or you won’t be taken serious Pinocchio
We are witnessing the "tide lifting all boats" type rally. The bio index and general indexes broke to the upside on expanding volume this week, AMRN is riding index coat tails (fine with me... my 50MA target has been met).
I'm long and expecting follow through to the upside tomorrow on the heels of strong momentum/price action, as well as a strong general market reversal that has put a stiff wind in AMRN's sails (IBB printed a bullish engulfing bar reversal).